Understanding the benefit of metformin use in cancer treatment

by Dowling, Ryan JO, Goodwin, Pamela J, Stambolic, Vuk
Published 2011

25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1

by Amir, Eitan, Cecchini, Reena S., Ganz, Patricia A., Costantino, Joseph P., Beddows, Samantha, Hood, Nicola, Goodwin, Pamela J.
Published 2012

Association Between Metformin Therapy and Mortality After Breast Cancer: A population-based study

by Lega, Iliana C., Austin, Peter C., Gruneir, Andrea, Goodwin, Pamela J., Rochon, Paula A., Lipscombe, Lorraine L.
Published 2013

Erratum to: 25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1

by Amir, Eitan, Cecchini, Reena S., Ganz, Patricia A., Costantino, Joseph P., Beddows, Samantha, Hood, Nicola, Goodwin, Pamela J.
Published 2012

Polymorphisms cMyc-N11S and p27-V109G and breast cancer risk and prognosis

by Figueiredo, Jane C, Knight, Julia A, Cho, Stewart, Savas, Sevtap, Onay, U Venus, Briollais, Laurent, Goodwin, Pamela J, McLaughlin, John R, Andrulis, Irene L, Ozcelik, Hilmi
Published 2007

Changes in insulin receptor signaling underlie neoadjuvant metformin administration in breast cancer: a prospective window of opportunity neoadjuvant study

by Dowling, Ryan JO, Niraula, Saroj, Chang, Martin C, Done, Susan J, Ennis, Marguerite, McCready, David R, Leong, Wey L, Escallon, Jaime M, Reedijk, Michael, Goodwin, Pamela J, Stambolic, Vuk
Published 2015